S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
OTCMKTS:IMPUY

Impala Platinum (IMPUY) Stock Price, News & Analysis

$5.02
-0.06 (-1.18%)
(As of 04/19/2024 ET)
Today's Range
$5.00
$5.14
50-Day Range
$3.14
$5.36
52-Week Range
$3.09
$10.30
Volume
116,886 shs
Average Volume
278,966 shs
Market Capitalization
$4.54 billion
P/E Ratio
N/A
Dividend Yield
2.19%
Price Target
N/A
IMPUY stock logo

About Impala Platinum Stock (OTCMKTS:IMPUY)

Impala Platinum Holdings Limited engages in the mining, processing, concentrating, refining, and sale of platinum group metals (PGMs) and associated base metals. The company produces platinum, palladium, rhodium, nickel, and by-products, as well as ruthenium, iridium, and gold. It has operations on the PGM-bearing orebodies, including the Bushveld Complex located in South Africa; and the Great Dyke situated in Zimbabwe, as well as the Canadian Shield. The company markets and sells its products in South Africa, Japan, China, the United States, and Europe. Impala Platinum Holdings Limited was incorporated in 1957 and is based in Sandton, South Africa.

IMPUY Stock Price History

IMPUY Stock News Headlines

Impala Platinum Holdings Limited (IMPUY)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
IMPUY Impala Platinum Holdings Limited
Impala Platinum Holdings Ltd PK (IMPUY)
Impala Platinum Holdings Ltd ADR
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Impala Platinum Holdings Ltd. ADR
Impala Platinum Mining Accident Death Toll Rises to 13
See More Headlines
Receive IMPUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Impala Platinum and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Metal mining
Sub-Industry
N/A
Current Symbol
OTCMKTS:IMPUY
CIK
N/A
Employees
39,834
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.01 billion
Cash Flow
$1.67 per share
Book Value
$8.20 per share

Miscellaneous

Free Float
N/A
Market Cap
$4.59 billion
Optionable
Not Optionable
Beta
1.69
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Nicolaas Johannes Muller B.Sc. (Age 58)
    Mining Eng., CEO & Executive Director
    Comp: $4.68M
  • Ms. Meroonisha Kerber B.Com. (Age 51)
    C.A., CFO, Debt Officer & Executive Director
    Comp: $2.17M
  • Mr. Mark Munroe
    Group Chief Technical Officer
  • Ms. Kirthanya Pillay
    Group Executive of Corporate Development
  • Mr. Sifiso Sibiya
    Group Executive of Refining & Marketing
  • Ms. Lee-Ann N. Samuel B.A. (Age 47)
    Group Executive of People & Executive Director
    Comp: $1.9M
  • Mr. Johan Theron
    Group Executive of Corporate Affairs
  • Mr. Jonathan Andrews
    Group Executive of Health & Safety
  • Mr. Tebogo T. Llale
    Company Secretary
  • Mr. Tim Hill
    Chief Executive Officer of Impala Canada

IMPUY Stock Analysis - Frequently Asked Questions

Should I buy or sell Impala Platinum stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Impala Platinum in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" IMPUY shares.
View IMPUY analyst ratings
or view top-rated stocks.

How have IMPUY shares performed in 2024?

Impala Platinum's stock was trading at $4.9160 at the beginning of the year. Since then, IMPUY shares have increased by 3.3% and is now trading at $5.08.
View the best growth stocks for 2024 here
.

Are investors shorting Impala Platinum?

Impala Platinum saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 16,100 shares, a decrease of 81.6% from the March 15th total of 87,700 shares. Based on an average trading volume of 422,500 shares, the short-interest ratio is currently 0.0 days.
View Impala Platinum's Short Interest
.

How often does Impala Platinum pay dividends? What is the dividend yield for Impala Platinum?

Impala Platinum declared a dividend on Thursday, September 21st. Stockholders of record on Friday, September 22nd will be given a dividend of $0.0577 per share on Tuesday, October 3rd. The ex-dividend date of this dividend is Thursday, September 21st.
Read our dividend analysis for IMPUY
.

Is Impala Platinum a good dividend stock?

Impala Platinum (OTCMKTS:IMPUY) pays an annual dividend of $0.11 per share and currently has a dividend yield of 2.16%.
Read our dividend analysis for IMPUY.

How do I buy shares of Impala Platinum?

Shares of IMPUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IMPUY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners